BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ABR--Affinity BioReagents Expands 100% Quality Guarantee


9/28/2007 8:00:29 AM

DENVER and GOLDEN, Colo., Sept. 28 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, strengthens researcher confidence with an expanded 100% Quality Guarantee.

Launched in 2003, the ABR-Affinity BioReagents Quality Pledge was established to bolster confidence in research antibodies. Antibodies are considered by many to be the building blocks of early-stage life science research and drug discovery. "Our Quality Guarantee Program was begun as a response to the frustration expressed by many of our scientific research partners", said Ken Wilczek, President of ABR-Affinity BioReagents. "We created a safety net for customers who may have limited resources. The response within the life science community has been overwhelmingly positive for over 5 years now."

One of the few antibody companies promoting this type of comprehensive guarantee, ABR stands firmly behind it. If an ABR product does not perform as specified on the product data sheet, ABR will completely refund or replace the full value of the product.

Today, ABR has announced the Innovator's Program to further advance quality in antibodies. If an ABR product does not perform in a previously untested or undocumented application or species, ABR will refund 80% of the purchase price. "Often a researcher requires a reagent for use with a particular species or in a specific application in which the product is untested. ABR's Innovator's Program is an opportunity to apply existing products to innovative models in a shared-risk environment. This offers the researcher the financial flexibility to think outside of the box," explains Mr. Wilczek.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 33,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry -- research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.

ABR-Affinity BioReagents

CONTACT: Leslie Martin of ABR media relations, 1-800-527-4535


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->